The GI Cancer Institute saves lives by funding gastrointestinal cancer research and promoting clinical trials. Gastro-Intestinal (GI) cancers include those of the oesophagus, stomach, liver, gall bladder, pancreas, small intestine, bowel and anus.
The GI Cancer Institute fundraise , raise awareness about GI cancers and share information about the latest clinical trials and research.
Role of pathology in GI cancers
GI cancers are the most common form of cancer, directly affecting more than 24,000 Australians each year and claiming a devastating 33 lives each day.
Pathology plays a vital role in the diagnosis and treatment of all types of GI cancers. Clinical trials also rely heavily on pathology to select participants and find better ways to treat GI cancers. These trials have seen improvements in both the life expectancy and quality of life of people diagnosed with these cancers.